<?xml version="1.0" encoding="utf-8"?>
<html madcap:lastblockdepth="4" madcap:lastheight="878" madcap:lastwidth="701" xmlns:madcap="http://www.madcapsoftware.com/Schemas/MadCap.xsd">
 <head>
 </head>
 <body>
  <h1>
   DRAXIS Specialty Pharmaceuticals Inc.
  </h1>
  <div style="display: none;">
   <table cellspacing="1" class="TableStyle-dnb_tablestyle_1" style="mc-table-style: url('../Resources/TableStyles/dnb_tablestyle_1.css');">
    <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
    </col>
    <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
    </col>
    <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
    </col>
    <thead>
     <tr class="TableStyle-dnb_tablestyle_1-Head-Header1">
      <th class="TableStyle-dnb_tablestyle_1-HeadE-Column1-Header1">
       DUNS
      </th>
      <th class="TableStyle-dnb_tablestyle_1-HeadE-Column1-Header1">
       Hoovers ID
      </th>
      <th class="TableStyle-dnb_tablestyle_1-HeadD-Column1-Header1">
       Tier
      </th>
     </tr>
    </thead>
    <tbody>
     <tr class="TableStyle-dnb_tablestyle_1-Body-Body1">
      <td class="TableStyle-dnb_tablestyle_1-BodyB-Column1-Body1" style="text-align: center;">
        243604761
      </td>
      <td class="TableStyle-dnb_tablestyle_1-BodyB-Column1-Body1" style="text-align: center;">
       48104
      </td>
      <td class="TableStyle-dnb_tablestyle_1-BodyA-Column1-Body1" style="text-align: center;">
       2
      </td>
     </tr>
    </tbody>
   </table></div><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Synopsis.flsnp" /><p>
   Jubilant DraxImage (JDI) develops and manufactures radiopharmaceuticals used in the detection and treatment of diseases including thyroid cancer. (Radiopharmaceuticals are drugs that contain radioactive materials; they can be used in imaging tests or for the delivery of radiation.) The firm's specializations, in addition to thyroid disorders, include cardiac, bone, kidney, brain, and lung imaging. Key products include I-131 Therapeutic &amp; Diagnostic capsules (thyroid), Methylene-Diphosphonate (bone), and MacroAggregated Albumin (lung). JDI provides its radiopharmaceuticals to nuclear medicine physicians and technicians as well as specialized radiopharmacies. The firm is a unit of India's Jubilant Life Sciences.
  </p><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Geographic Reach.flsnp" />
  <p>
   JDI operates in 25 nations in North America, Latin America, and Europe; it also operates in India.
  </p>
  <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Strategy.flsnp" />
  <p>
   The company is seeking to expand its share of the radiopharmaceutical market in North America. It also hopes to expand in Latin America, Europe, and Asia, which it plans to do by creating new distribution channels and through partnerships and collaborations with other companies. In 2015 it entered the Colombian market when it launched thyroid ablation therapy HICON Sodium Iodine I-131 Solution there.
  </p>
 <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /></body>
</html>
